"With the proposed tariff of around 500%, doing business with the US is out of the question right now. It will very badly affect exporters in textiles, engineering goods, pharmaceuticals, toys, and gems and jewellery," Mehta told ANI in an exclusive interview in the national capital. He d
The Indian Pharmaceutical Market (IPM) concluded 2025 with a valuation of approximately Rs 2,40,672 crore, reflecting a value growth of 8.1 per cent. According to the Pharmarack Indian Pharma Industry Performance report, IPM is likely to maintain the same growth range of 7.8-8.1% in 2026 as
Listed healthcare companies are expected to deliver strong growth in the third quarter of FY26, supported by robust performance across hospitals, diagnostics and pharmacy segments, highlighted a report by Nuvama.
Bangalore (Karnataka) [India], January 5: Pharmed, one of India's fastest-growing pharmaceutical companies, along with the Indian Orthopaedic Association's (IOA) Osteoporosis Council recently unveiled the Indian Osteoporosis Guidelines 2025 at IOACON 2025 in Guwahati. The Indian Orthopaedic
In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth by 0.5-1%. Prices are anticipated to be 30-50% lower than current levels initially, with the potential for deeper cuts of up to 70-75% o
New Delhi [India], January 3: Sunil Kumar, an entrepreneur with a strong vision for transforming healthcare accessibility, has officially launched AffordPill, a comprehensive online pharmacy and healthcare platform aimed at making essential medicines and healthcare services more affordable
Union Minister of Health and Family Welfare, Jagat Prakash Nadda, today held a comprehensive review meeting with the Health Ministers and senior officials of Rajasthan and Maharashtra to evaluate healthcare delivery mechanisms and fast-track the implementation of priority national health
Union Minister for Health and Family Welfare and Chemicals and Fertilizers, J. P. Nadda, today released the Indian Pharmacopoeia 2026 (IP 2026) - the 10th edition of India's official book of drug standards at Dr. Ambedkar International Centre, New Delhi, marking a significant milestone in
Nadda highlighted that the Indian Pharmacopoeia serves as the official book of standards for drugs in the country and is a cornerstone of India's regulatory framework for pharmaceuticals. He stated that the 10th edition reflects scientific advancements, global best practices, and India's gro
In a major step to ensure the safety of people, the government of India on Monday Proposed amendments for strict criteria on the sale of cough syrups over the counter. The Union government has issued a draft of an important amendment to the Drugs Rules-1945. The Health Ministry has propos
The Government of India has banned the manufacture of the painkiller nimesulide and has also prohibited the sale of all oral formulations of this popular painkiller containing more than 100 mg.
Referring to the Prime Minister's recent 'Mann Ki Baat' address, in which he emphasised the need to check upon the unchecked sale of antibiotics, AIOCD said that ICMR findings underline a national health emergency where commonly used antibiotics for pneumonia and urinary tract infections